Chymotrypsin is a member of the trypsin family of serine proteases and is o
ne of the first proteins successfully studied by X-ray crystallography. It
is secreted into the intestine as the inactive precursor chymotrypsinogen;
four sequential cleavages of the peptide bonds following residues 13, 15, 1
46 and 148 occur to generate the active pi, delta, kappa and alpha forms of
chymotrypsin. C-13 NMR has shown [O'Connell & Malthouse (1995). Biochem. J
, 307, 353-359] that when the delta form of chymotrypsin is inhibited by 2-
C-13-enriched benzyloxycarbonylglycylglycylphenylalanyl chloromethane, a te
trahedral adduct is formed which is thought to be analogous to the tetrahed
ral intermediate formed during catalysis, This inhibitor complex has bean c
rystallized as a dimer in space group P4(1)2(1)2. The structure has been re
fined at 2.14 Angstrom resolution to an R value of 21.2% (free R = 25.2%),
Conformational differences between delta-chymotrypsin and chymotrypsinogen
in the region of the flexible autolysis loop (residues 145-150) were observ
ed. This is the first crystal structure of S-chymotrypsin and includes two
residues which are disordered in previous crystal structures of active chym
otrypsin. A difference of 11.3 Angstrom(2) between the average Zz values of
the monomers within the asymmetric unit is caused by lattice-disordering e
ffects approximating to rotation of the molecules about a crystallographic
screw axis, The substrate-binding mode of the inhibitor was similar to othe
r chymotrypsin peptidyl inhibitor complexes, but this is the first publishe
d chymotrypsin structure in which the tetrahedral chloromethyl ketone trans
ition-state analogue is observed, This structure is compared with that of a
similar tetrahedral transition-state analogue which does not alkylate the
active-site histidine residue.